CBR01071
1-(3-Pyridin-4-yl-1,2,4-oxadiazol-5-yl)ethanamine trifluoroacetate salt
AldrichCPR
Manufacturer: Sigma Aldrich
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 G | CBR01071-1-G | In Stock | ₹ 10,770.88 |
CBR01071 - 1 G
In Stock
Quantity
1
Base Price: ₹ 10,770.88
GST (18%): ₹ 1,938.758
Total Price: ₹ 12,709.638
form
solid
SMILES string
NC(C)C1=NC(C2=CC=NC=C2)=NO1.OC(C(F)(F)F)=O
InChI
1S/C9H10N4O.C2HF3O2/c1-6(10)9-12-8(13-14-9)7-2-4-11-5-3-7;3-2(4,5)1(6)7/h2-6H,10H2,1H3;(H,6,7)
InChI key
VGHYACSWRBCLIC-UHFFFAOYSA-N
Related Products
Description
- Analysis Note: may contain up to 1.5 eq trifluoroacetate
- Other Notes: Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of unique chemicals. Sigma-Aldrich does not collect analytical data for this product. Buyer assumes responsibility to confirm product identity and/or purity. All sales are final.NOTWITHSTANDING ANY CONTRARY PROVISION CONTAINED IN SIGMA-ALDRICH′S STANDARD TERMS AND CONDITIONS OF SALE OR AN AGREEMENT BETWEEN SIGMA-ALDRICH AND BUYER, SIGMA-ALDRICH SELLS THIS PRODUCT "AS-IS" AND MAKES NO REPRESENTATION OR WARRANTY WHATSOEVER WITH RESPECT TO THIS PRODUCT, INCLUDING ANY (A) WARRANTY OF MERCHANTABILITY; (B) WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE; OR (C) WARRANTY AGAINST INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS OF A THIRD PARTY; WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE.
- Legal Information: Product of ChemBridge Corp.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 3 Oral
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
form: solid
SMILES string: NC(C)C1=NC(C2=CC=NC=C2)=NO1.OC(C(F)(F)F)=O
InChI: 1S/C9H10N4O.C2HF3O2/c1-6(10)9-12-8(13-14-9)7-2-4-11-5-3-7;3-2(4,5)1(6)7/h2-6H,10H2,1H3;(H,6,7)
InChI key: VGHYACSWRBCLIC-UHFFFAOYSA-N
form:
solid
SMILES string:
NC(C)C1=NC(C2=CC=NC=C2)=NO1.OC(C(F)(F)F)=O
InChI:
1S/C9H10N4O.C2HF3O2/c1-6(10)9-12-8(13-14-9)7-2-4-11-5-3-7;3-2(4,5)1(6)7/h2-6H,10H2,1H3;(H,6,7)
InChI key:
VGHYACSWRBCLIC-UHFFFAOYSA-N
form: solid
SMILES string: NCC1=NC(C2=CC=CN=C2)=NO1.OC(C(F)(F)F)=O
InChI: 1S/C8H8N4O.C2HF3O2/c9-4-7-11-8(12-13-7)6-2-1-3-10-5-6;3-2(4,5)1(6)7/h1-3,5H,4,9H2;(H,6,7)
InChI key: KHDQKQUFIFSFFO-UHFFFAOYSA-N
form:
solid
SMILES string:
NCC1=NC(C2=CC=CN=C2)=NO1.OC(C(F)(F)F)=O
InChI:
1S/C8H8N4O.C2HF3O2/c9-4-7-11-8(12-13-7)6-2-1-3-10-5-6;3-2(4,5)1(6)7/h1-3,5H,4,9H2;(H,6,7)
InChI key:
KHDQKQUFIFSFFO-UHFFFAOYSA-N
form: solid
SMILES string: NCCC1=NC(C2=CC=CN=C2)=NO1.OC(C(F)(F)F)=O
InChI: 1S/C9H10N4O.C2HF3O2/c10-4-3-8-12-9(13-14-8)7-2-1-5-11-6-7;3-2(4,5)1(6)7/h1-2,5-6H,3-4,10H2;(H,6,7)
InChI key: MTBZMBJODDSYIK-UHFFFAOYSA-N
form:
solid
SMILES string:
NCCC1=NC(C2=CC=CN=C2)=NO1.OC(C(F)(F)F)=O
InChI:
1S/C9H10N4O.C2HF3O2/c10-4-3-8-12-9(13-14-8)7-2-1-5-11-6-7;3-2(4,5)1(6)7/h1-2,5-6H,3-4,10H2;(H,6,7)
InChI key:
MTBZMBJODDSYIK-UHFFFAOYSA-N
form: solid
SMILES string: [H]O[H].[H]Cl.[H]Cl.[H]Cl.N1(CCN2CCNCC2)C=NC=N1
InChI: 1S/C8H15N5.3ClH.H2O/c1-3-12(4-2-9-1)5-6-13-8-10-7-11-13;;;;/h7-9H,1-6H2;3*1H;1H2
InChI key: WIRWEUIIQNHQCY-UHFFFAOYSA-N
form:
solid
SMILES string:
[H]O[H].[H]Cl.[H]Cl.[H]Cl.N1(CCN2CCNCC2)C=NC=N1
InChI:
1S/C8H15N5.3ClH.H2O/c1-3-12(4-2-9-1)5-6-13-8-10-7-11-13;;;;/h7-9H,1-6H2;3*1H;1H2
InChI key:
WIRWEUIIQNHQCY-UHFFFAOYSA-N